Joel Jules

940 total citations
22 papers, 773 citations indexed

About

Joel Jules is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Joel Jules has authored 22 papers receiving a total of 773 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 16 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Joel Jules's work include Bone Metabolism and Diseases (17 papers), Bone health and treatments (14 papers) and NF-κB Signaling Pathways (7 papers). Joel Jules is often cited by papers focused on Bone Metabolism and Diseases (17 papers), Bone health and treatments (14 papers) and NF-κB Signaling Pathways (7 papers). Joel Jules collaborates with scholars based in United States, China and Spain. Joel Jules's co-authors include Xu Feng, Zhenqi Shi, Jason W. Ashley, Guochun Zhu, Wei Chen, Selvarangan Ponnazhagan, Anandi Sawant, Jianzhong Liu, Jessy S. Deshane and Barry I. Hudson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Joel Jules

22 papers receiving 770 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joel Jules United States 18 492 290 170 127 116 22 773
Christina Böhm Germany 15 514 1.0× 250 0.9× 230 1.4× 216 1.7× 110 0.9× 20 871
Eva Gückel Germany 10 305 0.6× 135 0.5× 274 1.6× 77 0.6× 53 0.5× 12 559
Feiwu Kang China 9 280 0.6× 126 0.4× 60 0.4× 76 0.6× 137 1.2× 27 499
C. Manning United States 11 531 1.1× 203 0.7× 132 0.8× 297 2.3× 102 0.9× 15 832
Naohiko Hayakawa Japan 12 221 0.4× 153 0.5× 113 0.7× 170 1.3× 44 0.4× 20 594
Amy Y. Sato United States 13 560 1.1× 312 1.1× 57 0.3× 92 0.7× 79 0.7× 21 918
Motoyuki Uchida Japan 13 297 0.6× 111 0.4× 57 0.3× 61 0.5× 93 0.8× 18 658
Koichiro Takahi Japan 9 234 0.5× 138 0.5× 118 0.7× 161 1.3× 106 0.9× 20 480
Guochun Zhu United States 18 650 1.3× 252 0.9× 114 0.7× 168 1.3× 195 1.7× 25 882

Countries citing papers authored by Joel Jules

Since Specialization
Citations

This map shows the geographic impact of Joel Jules's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Jules with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Jules more than expected).

Fields of papers citing papers by Joel Jules

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel Jules. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Jules. The network helps show where Joel Jules may publish in the future.

Co-authorship network of co-authors of Joel Jules

This figure shows the co-authorship network connecting the top 25 collaborators of Joel Jules. A scholar is included among the top collaborators of Joel Jules based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel Jules. Joel Jules is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yuyu, Zhenqi Shi, Joel Jules, et al.. (2019). Specific RANK Cytoplasmic Motifs Drive Osteoclastogenesis. Journal of Bone and Mineral Research. 34(10). 1938–1951. 18 indexed citations
2.
Jules, Joel, Wei Chen, Xu Feng, & Yiping Li. (2017). C/EBPα transcription factor is regulated by the RANK cytoplasmic 535IVVY538 motif and stimulates osteoclastogenesis more strongly than c-Fos. Journal of Biological Chemistry. 293(4). 1480–1492. 11 indexed citations
3.
Jules, Joel, Yiping Li, & Wei Chen. (2017). C/EBPα and PU.1 exhibit different responses to RANK signaling for osteoclastogenesis. Bone. 107. 104–114. 10 indexed citations
4.
Kwak, Taekyoung, et al.. (2016). Regulation of Receptor for Advanced Glycation End Products (RAGE) Ectodomain Shedding and Its Role in Cell Function. Journal of Biological Chemistry. 291(23). 12057–12073. 27 indexed citations
5.
Jules, Joel, Wei Chen, Xu Feng, & Yiping Li. (2016). CCAAT/Enhancer-binding Protein α (C/EBPα) Is Important for Osteoclast Differentiation and Activity. Journal of Biological Chemistry. 291(31). 16390–16403. 17 indexed citations
6.
Gao, Bo, Liang Hao, Joel Jules, et al.. (2016). The silencing of cathepsin K used in gene therapy for periodontal disease reveals the role of cathepsin K in chronic infection and inflammation. Journal of Periodontal Research. 51(5). 647–660. 34 indexed citations
7.
Jules, Joel, Shuying Yang, Wei Chen, & Yiping Li. (2015). Role of Regulators of G Protein Signaling Proteins in Bone Physiology and Pathophysiology. Progress in molecular biology and translational science. 133. 47–75. 22 indexed citations
8.
Jules, Joel, Shunqing Wang, Zhenqi Shi, et al.. (2015). The IVVY Motif and Tumor Necrosis Factor Receptor-associated Factor (TRAF) Sites in the Cytoplasmic Domain of the Receptor Activator of Nuclear Factor κB (RANK) Cooperate to Induce Osteoclastogenesis. Journal of Biological Chemistry. 290(39). 23738–23750. 19 indexed citations
9.
Hao, Liang, Guochun Zhu, Yun Lü, et al.. (2015). Deficiency of cathepsin K prevents inflammation and bone erosion in rheumatoid arthritis and periodontitis and reveals its shared osteoimmune role. FEBS Letters. 589(12). 1331–1339. 61 indexed citations
10.
Jules, Joel & Xu Feng. (2014). In Vitro Investigation of the Roles of the Proinflammatory Cytokines Tumor Necrosis Factor-α and Interleukin-1 in Murine Osteoclastogenesis. Methods in molecular biology. 1155. 109–123. 14 indexed citations
11.
Wu, Mengrui, Yiping Li, Guochun Zhu, et al.. (2014). Chondrocyte-specific Knockout of Cbfβ Reveals the Indispensable Function of Cbfβ in Chondrocyte Maturation, Growth Plate Development and Trabecular Bone Formation in Mice. International Journal of Biological Sciences. 10(8). 861–872. 28 indexed citations
12.
13.
Jules, Joel, Dony Maiguel, & Barry I. Hudson. (2013). Alternative Splicing of the RAGE Cytoplasmic Domain Regulates Cell Signaling and Function. PLoS ONE. 8(11). e78267–e78267. 46 indexed citations
14.
Sawant, Anandi, et al.. (2012). Myeloid-Derived Suppressor Cells Function as Novel Osteoclast Progenitors Enhancing Bone Loss in Breast Cancer. Cancer Research. 73(2). 672–682. 139 indexed citations
15.
Jules, Joel, Ping Zhang, Jason W. Ashley, et al.. (2012). Molecular Basis of Requirement of Receptor Activator of Nuclear Factor κB Signaling for Interleukin 1-mediated Osteoclastogenesis. Journal of Biological Chemistry. 287(19). 15728–15738. 68 indexed citations
16.
Cheng, Jing, Jianzhong Liu, Zhenqi Shi, et al.. (2011). Molecular Mechanisms of the Biphasic Effects of Interferon-γ on Osteoclastogenesis. Journal of Interferon & Cytokine Research. 32(1). 34–45. 24 indexed citations
17.
Jules, Joel, Zhenqi Shi, Jianzhong Liu, et al.. (2010). Receptor Activator of NF-κB (RANK) Cytoplasmic IVVY535–538 Motif Plays an Essential Role in Tumor Necrosis Factor-α (TNF)-mediated Osteoclastogenesis. Journal of Biological Chemistry. 285(48). 37427–37435. 34 indexed citations
18.
Jules, Joel, Jason W. Ashley, & Xu Feng. (2010). Selective targeting of RANK signaling pathways as new therapeutic strategies for osteoporosis. Expert Opinion on Therapeutic Targets. 14(9). 923–934. 52 indexed citations
19.
Wang, Shunqing, Zhenqi Shi, Wei Liu, Joel Jules, & Xu Feng. (2006). Development and validation of vectors containing multiple siRNA expression cassettes for maximizing the efficiency of gene silencing. BMC Biotechnology. 6(1). 50–50. 28 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christina Böhm Breakdown of academic impact, for papers by Eva Gückel Breakdown of academic impact, for papers by Feiwu Kang Breakdown of academic impact, for papers by C. Manning Breakdown of academic impact, for papers by Naohiko Hayakawa Breakdown of academic impact, for papers by Amy Y. Sato Breakdown of academic impact, for papers by Motoyuki Uchida Breakdown of academic impact, for papers by Koichiro Takahi Breakdown of academic impact, for papers by Guochun Zhu
Rankless by CCL
2026